+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Liver And Kidney Disorders Drugs Market Research Reports

From
From
From
From
From
From
From
From
From
From
From
From
Liver Fibrosis Market - Product Thumbnail Image

Liver Fibrosis Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
Hepatic Disease Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hepatic Disease Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
Kidney Stone Management Market Report and Forecast 2024-2032 - Product Thumbnail Image

Kidney Stone Management Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 200 Pages
  • Global
From
Calciphylaxis Market Report and Forecast 2024-2032 - Product Thumbnail Image

Calciphylaxis Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
From
Alport Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Alport Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Acute Kidney Injury- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Kidney Injury- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Alcoholic Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Alcoholic Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share. The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market. Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more